rfhg_34674.1

Basic information about the TSS

---

TSS ID: rfhg_34674.1 Species: human Chr: chr2		Start: 171160515 End: 171160551 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3208228,EH38E2050826)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: D50927:0 AK292508:0 GeneID: 9874 HGNC/MGI_ID: HGNC:11841 UniProt_ID: A8K8Z3 Nearer transcript ids and distances: ENST00000413010.5:-13 ENST00000359766.7:20 AF162666:-30 BC032657:65 AB004885:-84 DQ890904:87 KJ905383:87 AB383761:87 DQ894057:87 ENST00000360843.7:-282 ENST00000431350.7:-342 NM_012290.5:-342 ENST00000409443.6:-349 AK091975:-349 view more...

Gene_name: tousled like kinase 1 Gene_symbol: TLK1 Gene_synonyms: KIAA0137 PKU-BETA Gene_source: HGNC:11841

TATA-Box annotation

---

Distance to TSS:	360
Nearest PromoterID:	NM_012290
Entrez ID:	9874
Nearest Unigene:	Hs.744917
Nearest Refseq:	NM_012290
Nearest Ensembl:	ENSG00000198586
Gene Name:	tousled like kinase 1
Gene Alias:	PKU-beta
Gene Type:	protein-coding
CpG%:	0.138889
GC%:	0.756757
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TLK1 p2@TLK1 p3@TLK1 p4@TLK1 p5@TLK1 p6@TLK1 p9@TLK1
Sample		p1@TLK1	p2@TLK1	p3@TLK1	p4@TLK1	p5@TLK1	p6@TLK1	p9@TLK1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.10	9.93	1.56	1.75	0.78	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.91	8.30	2.02	1.01	1.62	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.98	5.98	2.31	0.39	0.96	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.69	5.82	0.83	1.25	0.62	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.90	7.87	0.22	1.12	0.45	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.75	7.75	1.94	1.55	0.00	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.50	10.89	4.36	2.18	1.31	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.99	8.96	2.91	0.48	0.73	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.92	7.69	2.99	0.85	0.64	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.81	27.82	4.06	2.90	2.32	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.94	24.25	1.62	2.43	1.21	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.86	21.14	3.25	4.07	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.67	12.57	2.26	1.29	2.26	1.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.13	8.12	2.26	1.35	0.75	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	11.20	1.98	1.10	2.85	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	9.31	1.01	2.26	2.01	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.27	9.39	1.53	2.40	1.75	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	9.28	1.69	0.84	1.27	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	8.53	3.20	1.60	0.53	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.88	9.93	2.86	1.05	1.81	0.60	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.36	10.29	2.27	1.34	1.20	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.46	7.42	1.90	1.04	0.69	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.44	9.44	2.59	1.55	1.55	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	6.55	3.64	0.73	2.18	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	11.35	3.35	0.77	1.81	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.18	12.98	2.22	1.90	1.90	1.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	12.64	3.30	1.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.38	10.84	0.94	1.89	1.41	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.72	8.24	4.04	1.62	0.48	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.76	10.50	1.45	1.63	1.45	1.45	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.26	5.65	2.51	0.84	1.47	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.63	10.55	1.76	0.98	1.37	0.98	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.13	9.07	2.74	1.48	0.84	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.90	8.58	2.31	0.99	1.15	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.35	8.98	1.68	1.31	1.50	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.88	7.66	1.92	1.72	1.53	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.01	7.97	2.04	2.66	0.82	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.69	6.65	1.01	0.81	1.41	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.99	6.75	4.59	0.81	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.88	11.52	2.88	1.44	1.20	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.35	6.12	1.88	0.71	1.18	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.93	9.37	1.90	0.88	0.29	1.02	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.33	8.22	2.32	1.27	1.05	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.94	10.31	2.97	2.27	1.05	1.22	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.65	7.63	3.61	1.61	1.00	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	8.14	2.56	1.63	1.16	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	16.07	10.32	1.20	0.96	1.20	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.11	9.84	2.09	1.19	0.89	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	15.08	7.42	2.39	1.68	1.68	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.53	7.89	2.02	0.81	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.63	7.17	2.87	0.82	0.61	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.67	5.78	2.45	1.11	0.67	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.16	3.19	1.06	0.35	0.71	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.92	2.98	2.65	0.33	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	1.68	5.03	1.68	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	7.35	2.30	0.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.29	4.54	1.62	1.62	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.70	2.57	1.93	0.32	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.72	4.09	1.89	1.57	0.63	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	1.41	2.82	0.71	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	3.93	0.56	0.56	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	34.23	11.15	7.17	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	6.12	3.40	0.00	0.68	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.55	6.17	4.87	0.97	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	2.84	2.48	0.71	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	6.34	0.98	0.49	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.89	4.96	0.99	0.50	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.73	1.41	2.35	0.94	1.41	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.19	4.97	1.32	0.99	2.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.70	4.95	0.62	0.00	1.24	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	3.67	0.61	0.00	3.06	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	9.50	7.13	1.11	2.69	0.16	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	7.38	7.54	0.80	1.28	0.48	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	18.58	13.36	1.91	2.29	0.51	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	7.47	6.73	1.49	2.24	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	7.70	9.04	0.67	1.34	0.33	1.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	5.10	0.64	1.91	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	2.20	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	5.87	1.35	0.90	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	2.26	5.56	0.17	1.04	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.38	17.01	2.93	3.52	0.59	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	14.16	10.81	1.29	1.54	0.51	1.29	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	9.76	23.14	3.90	1.95	1.12	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	25.86	2.35	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.20	12.79	2.33	2.17	0.97	0.40	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	12.26	16.14	1.61	1.61	0.00	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	4.27	13.86	0.53	1.07	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	15.58	0.56	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	6.65	0.83	1.66	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	7.79	10.80	0.50	0.50	1.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.14	8.18	0.00	2.29	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	10.66	0.91	1.52	1.22	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	3.98	0.88	0.00	0.00	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.15	1.08	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.43	2.88	0.54	0.00	0.18	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.96	2.88	0.00	0.21	0.62	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.24	7.90	1.72	0.80	0.46	0.69	0.00
Anulus Pulposus Cell, donor2	11463-119B5	8.57	9.31	1.71	0.49	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	4.49	0.45	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.34	4.78	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	6.42	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.67	3.29	0.90	0.00	0.00	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	2.53	2.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	3.30	1.32	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.20	3.25	0.65	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.83	1.46	0.49	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.97	3.56	0.59	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.03	3.77	1.51	0.75	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	2.90	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.44	3.95	1.48	0.49	0.16	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.58	2.87	0.90	0.75	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	4.29	0.54	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.35	5.48	0.57	0.57	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.29	4.01	0.53	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	0.98	1.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.64	5.81	1.33	0.17	0.17	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	3.60	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.46	2.57	1.89	0.34	0.17	0.69	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	2.91	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	5.69	1.52	1.14	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	3.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.27	3.42	1.71	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.20	3.42	0.86	0.64	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.39	2.32	1.03	0.00	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	4.22	1.41	0.47	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	1.93	0.96	0.96	0.32	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	0.00	0.00	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	2.34	0.00	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.83	3.31	0.90	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	3.56	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.05	6.10	1.02	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.88	5.35	1.02	0.00	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	1.27	1.27	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4.75	3.45	0.86	0.00	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.72	3.39	0.64	0.21	0.00	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.80	2.90	0.58	0.29	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	3.78	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.58	2.88	0.68	0.17	0.17	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	4.23	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.72	2.57	1.72	0.43	0.21	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	3.61	1.80	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	3.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.52	2.76	0.69	0.23	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	2.55	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.36	5.34	0.76	0.76	0.25	0.00	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.19	2.68	2.48	0.21	0.21	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.20	3.67	0.61	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.26	4.78	0.96	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4.66	4.66	0.89	1.11	0.22	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	5.54	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.50	3.44	1.59	0.79	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	3.27	1.09	0.00	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	4.42	9.09	0.25	0.74	0.37	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	3.77	3.25	0.68	0.34	0.17	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.89	5.03	0.21	0.21	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	9.41	17.08	2.79	1.39	1.05	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	13.91	10.84	4.04	1.46	1.13	1.46	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	10.44	15.36	2.54	1.34	1.94	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	69.38	43.70	11.70	4.47	8.26	0.80	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.29	44.98	11.90	3.26	10.52	0.38	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	67.37	46.20	11.38	4.78	9.33	0.80	0.91
Basophils, donor1	12241-129G9	18.57	4.18	0.78	0.52	0.52	0.00	0.26
Basophils, donor2	12242-129H1	47.26	15.87	2.89	0.72	0.00	0.00	2.16
Basophils, donor3	12243-129H2	23.08	9.11	1.62	1.18	0.59	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.31	3.45	0.22	0.43	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	3.20	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	4.39	0.00	0.63	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.45	2.29	0.42	0.83	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.60	2.53	0.23	1.15	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.53	12.06	1.80	3.24	0.72	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	30.20	10.92	6.29	1.55	1.24	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	47.98	22.59	5.12	5.12	1.63	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	31.66	15.67	7.35	1.28	0.00	2.24	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	24.23	18.03	2.82	5.07	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	37.49	15.78	3.16	3.53	1.11	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	43.25	14.71	2.20	5.27	1.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.17	24.06	5.38	2.55	1.13	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.04	29.19	3.79	5.69	1.14	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.09	36.49	3.94	3.62	1.64	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	47.70	15.03	1.45	3.90	0.87	0.43	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	37.42	13.88	2.11	2.41	0.91	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	46.19	11.61	1.18	3.55	0.95	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.29	9.88	0.33	2.85	0.33	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	38.92	7.18	1.10	5.52	1.38	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.30	6.69	0.50	5.95	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	24.28	8.81	1.17	3.72	0.98	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.24	8.72	0.18	2.14	0.89	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.63	7.40	1.31	0.87	0.44	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.79	8.43	1.17	0.70	0.47	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.95	8.45	0.53	3.17	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	2.22	1.11	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.52	10.41	0.59	3.42	0.89	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	45.50	9.58	2.00	3.59	0.20	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.19	5.62	1.67	2.50	0.00	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	22.65	8.69	0.69	1.14	0.46	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.81	7.69	0.45	2.71	0.45	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	5.24	0.44	0.44	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.54	13.72	1.08	3.50	0.27	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.68	14.83	1.22	4.71	1.74	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	38.29	12.20	0.84	2.10	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	21.13	11.02	0.73	3.86	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	40.51	15.50	0.70	7.75	2.82	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.01	9.65	0.88	5.26	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.83	12.90	1.74	5.93	1.39	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.33	8.55	1.12	2.60	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.08	9.27	0.86	3.02	1.51	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.98	15.97	2.46	5.73	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	18.78	11.82	0.70	3.71	0.23	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.76	7.19	0.93	4.18	0.46	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	18.96	4.58	0.44	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	20.33	6.47	0.69	2.08	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	13.65	4.77	0.43	0.65	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	30.21	12.46	0.93	2.02	0.78	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	17.81	13.97	1.22	1.05	0.35	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	48.83	19.40	1.34	1.34	0.67	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	17.35	7.14	0.51	0.51	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	27.88	6.37	0.22	1.32	0.88	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	20.84	6.32	0.21	0.42	0.84	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	12.19	2.03	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.75	25.76	7.46	7.46	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	52.82	22.78	4.14	2.07	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	49.04	36.78	3.73	4.80	2.13	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	43.42	5.36	4.82	2.68	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	58.26	26.67	7.02	4.21	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.12	31.37	4.71	3.14	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	65.91	27.68	7.91	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	129.86	43.56	5.75	10.68	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	89.23	32.64	3.63	2.18	4.35	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	101.47	39.88	5.05	7.07	4.04	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	24.65	2.83	3.64	2.02	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.98	22.77	0.40	2.00	1.20	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	36.15	11.04	6.02	3.01	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	34.83	25.28	6.74	3.37	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.68	12.40	4.51	1.88	1.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	30.21	13.98	5.41	1.80	0.90	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	149.25	71.05	20.71	22.14	2.50	0.00	1.79
CD4+ T Cells, donor2	11306-117C1	140.84	72.87	17.15	15.92	1.84	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	118.34	55.20	18.60	13.11	4.57	0.91	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.79	21.18	2.04	1.53	0.51	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	83.10	21.11	3.37	2.70	0.90	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	78.76	25.01	2.01	2.59	2.30	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	70.17	40.30	13.27	6.16	0.95	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.85	35.12	7.73	8.43	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	36.26	6.59	6.59	6.59	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	55.78	19.94	2.60	1.88	1.30	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	79.31	23.89	4.07	3.39	1.86	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.06	20.96	3.39	2.74	1.13	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	65.00	19.28	4.48	1.79	0.90	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	78.96	25.16	6.29	1.75	1.05	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	107.80	34.76	4.84	3.52	0.44	0.44	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	72.52	37.53	3.79	1.69	1.26	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	105.55	23.27	4.78	3.74	2.49	0.21	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	82.53	24.73	3.68	1.34	2.34	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	95.72	70.97	15.50	12.24	1.63	1.09	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	115.23	76.10	19.29	10.18	1.07	0.54	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	86.07	50.21	17.93	3.59	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	76.21	27.63	3.15	0.93	1.11	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.22	19.50	4.55	2.38	0.65	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	71.66	19.96	2.94	2.10	1.26	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.19	37.41	16.18	10.62	1.52	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	62.39	35.09	10.83	9.10	1.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	91.96	45.76	16.56	5.23	0.87	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	55.43	31.67	9.40	0.49	3.96	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	43.39	34.16	7.39	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	12.56	1.40	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.34	43.75	13.29	1.11	1.11	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	57.42	37.54	10.80	1.23	1.23	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	27.72	9.24	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.95	30.44	6.80	1.79	1.07	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	19.39	6.92	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	77.27	24.88	7.53	3.27	2.29	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	76.21	25.15	6.01	5.26	1.88	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	89.89	42.67	7.57	10.35	1.51	0.25	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.36	5.51	0.00	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.79	3.35	0.24	0.24	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	6.02	0.00	0.55	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	3.30	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.08	2.88	1.20	0.24	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.68	3.64	0.91	0.68	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.21	4.78	0.87	0.00	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.79	5.26	1.05	0.26	0.79	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.86	4.69	0.47	0.00	0.70	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.72	6.64	0.60	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.20	6.39	1.16	0.29	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.80	8.53	0.53	1.07	0.53	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	5.69	0.44	1.75	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.56	5.92	0.91	1.37	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	11.93	2.24	2.98	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.96	6.12	0.36	1.08	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	5.75	0.58	1.15	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.48	4.01	0.47	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.39	4.12	0.95	0.95	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.31	3.38	1.54	0.00	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.81	4.49	0.00	0.32	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	5.74	0.38	0.00	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.73	7.88	0.00	0.79	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	5.29	0.00	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	20.07	0.00	1.61	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	20.28	1.40	0.70	1.40	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	14.02	25.04	1.00	6.01	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	25.59	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	4.94	2.47	0.49	0.00	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	4.10	4.00	1.26	0.11	0.32	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	11.09	15.60	3.12	1.73	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.91	1.78	0.36	0.36	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	6.03	7.17	1.14	0.91	0.80	0.46	0.00
Chondrocyte - re diff, donor2	11339-117F7	3.58	8.06	1.79	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.68	6.07	0.81	1.62	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	11.59	18.36	2.98	1.61	1.38	0.46	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	11.33	11.54	1.71	0.64	0.43	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	13.01	12.21	2.39	0.62	1.50	0.27	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	23.84	25.31	2.02	1.74	2.11	1.19	0.73
Corneal Epithelial Cells, donor1	11526-119I5	3.07	4.17	0.22	0.88	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	4.55	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.60	4.60	0.26	0.51	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	48.87	9.91	1.82	2.48	2.15	0.00	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.84	9.15	2.84	1.89	2.52	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	3.45	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.89	7.88	1.51	2.16	1.51	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	39.97	37.92	11.27	5.47	0.68	0.00	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	17.63	21.54	8.49	5.22	0.65	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.97	26.13	12.10	5.32	0.97	1.45	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	5.50	3.17	0.67	0.17	0.67	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	1.17	0.59	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.37	4.52	0.00	0.00	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	8.65	3.93	1.18	0.00	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.07	4.36	0.58	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	6.59	9.65	1.18	0.71	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	4.73	2.45	0.70	0.53	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.29	11.53	1.99	0.89	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.21	12.47	1.22	0.91	0.91	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.42	13.81	1.41	1.13	0.85	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	5.05	4.46	0.00	0.30	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	3.12	0.00	0.52	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.09	1.99	1.42	0.00	0.43	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	7.60	0.00	0.00	0.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	3.14	4.72	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.35	18.89	3.23	2.36	1.24	1.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.11	23.25	1.52	2.82	1.30	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.11	21.37	2.32	1.47	1.34	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	1.40	0.70	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	7.38	5.50	0.47	0.79	0.47	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	30.49	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	23.10	4.95	4.95	1.65	1.65	0.00	3.30
Eosinophils, donor3	12246-129H5	32.10	7.13	7.13	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.15	2.20	0.24	0.24	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.37	8.21	1.64	2.46	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.02	3.50	0.88	0.55	0.00	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.04	8.34	1.95	0.87	0.43	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.58	8.25	1.70	0.49	0.36	0.36	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.24	17.06	3.55	4.50	1.50	0.14	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.28	11.81	2.32	0.84	0.53	0.53	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.17	13.96	1.84	0.79	0.00	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	7.97	2.33	0.33	1.33	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	5.90	6.35	1.36	0.45	1.36	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	3.03	2.27	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.36	3.15	1.10	0.63	0.47	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	11.82	11.52	2.73	0.91	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.31	6.98	1.65	0.63	0.51	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	9.85	5.61	2.88	0.91	0.45	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.70	7.77	0.94	0.40	0.54	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	8.20	0.86	0.86	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	11.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	4.61	5.30	0.23	0.46	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	8.99	9.33	2.20	0.85	0.34	0.85	0.17
Fibroblast - Dermal, donor1	11269-116G9	4.70	6.34	0.47	0.94	0.94	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	2.36	4.72	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.84	5.56	0.60	0.48	0.73	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	12.21	8.48	2.15	1.02	0.68	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	13.08	9.94	1.22	0.70	0.52	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	14.78	7.31	1.95	1.30	0.65	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	13.74	11.87	0.42	0.62	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.70	11.27	2.36	2.62	0.79	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	10.28	9.36	1.58	0.53	0.40	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	16.05	14.12	2.13	1.74	0.97	1.06	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	15.58	10.39	4.16	2.08	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.74	19.03	2.11	2.11	1.06	1.06	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.56	12.94	2.65	1.09	0.62	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.06	11.63	1.35	1.22	0.27	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	39.88	45.17	1.76	4.59	3.18	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.84	16.96	1.32	2.92	1.17	0.73	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.14	11.86	1.91	1.23	0.27	0.82	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.76	19.85	2.63	1.54	0.77	0.77	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.41	22.60	1.91	2.05	0.73	1.32	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	7.46	1.49	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	6.96	3.17	0.42	0.21	0.42	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	6.66	0.83	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	2.80	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.93	8.93	0.00	0.81	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.25	9.50	0.97	0.58	0.78	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	15.32	16.23	1.52	0.61	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.17	18.67	2.75	0.61	0.61	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.65	14.12	1.91	1.53	0.38	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	10.53	11.07	1.08	0.81	0.54	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.83	17.16	0.93	1.74	1.16	0.70	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.07	3.21	1.66	0.44	0.11	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.50	4.47	0.00	0.61	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.67	2.67	1.34	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.93	3.95	1.19	0.79	0.79	1.58	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.12	12.90	1.39	0.99	0.40	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.86	9.95	0.89	0.36	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	8.67	7.29	1.58	0.79	0.79	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.83	7.22	1.20	0.60	0.00	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.47	8.96	2.05	0.86	0.65	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.92	10.12	2.28	1.01	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.35	7.71	1.80	0.49	0.82	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.84	13.83	2.41	1.00	0.60	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	10.65	6.83	1.41	0.80	0.10	0.60	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.23	12.09	1.81	1.21	0.00	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.77	10.11	0.91	0.99	0.33	0.58	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	11.97	12.31	1.71	0.51	0.51	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.51	10.84	0.99	1.31	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.55	6.28	1.70	0.64	0.21	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	8.60	5.57	1.18	0.51	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	3.29	2.04	0.31	0.00	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	49.68	13.94	4.36	2.61	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.56	8.32	1.56	1.21	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.40	12.75	1.04	1.82	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.42	9.71	1.28	4.09	0.77	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	23.73	5.36	4.59	1.53	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	24.88	7.66	2.55	0.64	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	26.24	57.34	7.13	7.13	4.28	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	25.92	82.73	6.34	9.93	8.00	3.03	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.41	45.44	9.36	5.25	3.65	1.37	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	25.56	64.59	4.36	8.12	5.94	1.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.34	73.75	4.49	8.19	5.82	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.92	44.03	8.81	5.22	4.89	2.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.44	62.35	5.75	5.75	3.98	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.34	26.43	7.21	2.54	1.98	1.84	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.82	25.24	8.62	2.22	2.71	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.33	24.71	7.79	2.69	0.54	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	6.57	17.47	2.73	2.11	2.60	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.06	20.21	4.57	1.52	1.94	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.90	21.35	3.46	1.42	1.22	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.30	16.66	2.51	1.37	2.28	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.10	16.57	2.99	2.24	1.62	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.80	21.42	4.81	4.37	2.40	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.09	20.39	2.36	0.89	2.66	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.95	21.46	3.34	1.75	1.43	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.28	24.13	4.92	2.46	4.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6.25	15.73	2.42	1.01	1.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	7.46	12.89	3.22	0.85	1.87	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	14.10	25.09	5.76	2.31	1.42	0.53	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.60	28.93	2.08	1.04	2.71	0.62	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.17	24.25	1.88	1.88	1.37	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	7.97	17.70	2.66	1.11	1.99	0.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.07	21.30	2.66	1.25	1.08	0.75	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.53	18.78	1.02	1.63	0.61	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4.33	14.44	2.68	1.24	1.86	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.07	16.60	1.61	0.69	1.73	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.50	18.51	1.83	2.00	1.00	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	5.07	12.56	1.32	1.54	2.20	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	6.52	14.51	2.95	1.84	1.60	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	6.00	17.67	2.92	0.65	2.59	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	4.81	21.17	0.32	1.28	3.21	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.21	11.65	1.71	1.04	1.99	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5.54	13.13	0.63	0.95	2.37	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	4.56	14.29	2.74	0.30	2.13	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	6.38	11.19	1.88	0.84	1.36	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	6.59	13.61	1.98	0.88	1.76	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5.33	12.06	0.84	0.84	1.40	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.65	12.31	1.85	0.74	1.11	0.65	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.88	7.22	1.34	0.53	0.53	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	4.74	9.49	1.38	0.15	0.92	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	6.22	8.81	1.04	0.52	1.04	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	6.78	13.28	3.52	1.36	1.36	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	4.79	13.83	1.11	0.74	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.70	10.97	2.85	0.66	0.66	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	25.79	3.97	0.99	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	4.62	9.10	1.32	0.40	0.92	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	5.25	9.28	1.01	0.20	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.44	40.41	2.54	3.81	2.29	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.92	37.82	13.34	2.39	0.80	1.79	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.02	33.90	12.94	2.62	2.62	1.39	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.98	45.21	11.87	4.09	2.86	2.45	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.63	25.35	4.69	1.56	1.88	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.80	17.24	1.70	2.26	0.28	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.69	32.75	7.38	2.31	2.31	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	14.85	4.95	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.38	22.43	10.06	0.39	1.93	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	40.11	3.21	3.21	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	19.13	10.43	3.48	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	12.37	18.55	5.86	2.93	1.63	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.77	29.24	4.94	3.29	1.65	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	53.32	13.33	3.33	3.33	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.07	21.53	2.80	1.68	0.28	1.12	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.82	19.61	7.19	3.60	2.29	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	30.20	6.71	1.68	2.52	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.36	27.67	4.13	2.23	1.27	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.83	19.02	3.74	1.70	1.36	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	14.62	10.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	26.34	2.86	1.15	1.72	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.37	15.69	1.48	1.48	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	20.33	5.08	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	21.95	4.14	2.49	1.24	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	9.44	27.39	3.91	2.30	3.91	2.07	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.00	21.53	3.84	2.69	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.82	17.28	2.28	1.96	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	6.02	22.07	2.68	2.01	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.63	30.05	1.93	2.31	1.54	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	20.88	38.00	7.19	4.79	2.05	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	42.24	0.00	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.97	30.67	1.42	2.36	3.30	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.05	25.95	1.21	0.60	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	6.61	28.99	2.03	3.56	1.53	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	9.17	32.31	1.20	0.40	1.99	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	6.91	22.69	2.47	1.97	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	33.05	0.00	4.72	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.17	23.92	1.17	1.75	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	6.58	29.41	1.32	3.95	3.07	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	10.17	27.97	0.85	2.54	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	14.33	1.79	0.00	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.76	14.07	3.40	1.94	0.00	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	3.33	8.32	0.00	2.08	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	4.50	0.00	0.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.12	3.81	0.32	0.32	0.00	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	2.92	0.42	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.01	6.85	2.67	0.46	0.23	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.62	9.12	1.52	0.34	0.34	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.56	4.55	2.05	1.37	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.73	6.67	0.77	0.55	0.22	0.44	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.52	6.88	1.93	0.86	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.18	3.66	1.51	1.29	0.65	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.84	6.35	0.87	0.62	0.25	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	7.03	0.86	1.03	0.34	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.21	8.97	1.28	1.28	0.32	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	5.60	0.00	1.12	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	2.16	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.41	2.47	0.00	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	3.63	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	2.45	1.92	0.52	0.70	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	38.74	25.42	4.84	7.26	0.00	4.84	1.21
Hepatocyte, donor2	11603-120I1	35.55	17.24	1.08	1.08	2.15	2.15	0.00
Hepatocyte, donor3	11684-122I1	42.33	14.72	1.84	1.84	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.89	25.45	5.87	1.31	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.60	19.58	5.24	3.85	0.87	0.87	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.76	4.25	0.55	0.55	0.41	0.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	31.84	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	26.70	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	49.84	0.00	0.00	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	27.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	35.60	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	48.70	2.56	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	18.28	0.00	9.14	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	69.85	6.50	3.25	9.75	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	18.34	0.00	1.67	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	21.78	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	39.70	64.85	1.32	1.32	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	37.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	52.38	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.79	36.53	1.89	3.15	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	40.21	1.55	4.64	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	14.63	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	31.01	45.22	3.88	4.52	4.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	53.13	1.61	4.83	4.83	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	47.79	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	42.37	66.82	4.07	5.70	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.05	48.70	0.84	4.62	1.68	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	48.22	2.41	4.82	2.41	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	27.70	1.85	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	24.55	1.42	1.89	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	28.12	0.91	0.00	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	39.82	39.82	2.15	4.30	5.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	40.65	41.93	0.00	1.27	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.78	45.91	1.91	3.19	3.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	54.68	1.82	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	47.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.28	37.13	3.57	2.14	2.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	33.18	3.32	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	23.77	25.00	0.62	3.40	3.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	49.17	0.00	1.76	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	44.00	3.14	3.14	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	32.68	54.24	0.00	3.48	2.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	35.41	6.64	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	35.66	3.24	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.90	29.65	6.10	0.00	4.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	53.99	2.25	4.50	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	27.88	0.00	10.45	3.48	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	25.60	28.80	1.07	3.20	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	37.41	1.39	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	45.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	39.58	35.90	2.76	6.44	4.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	9.08	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	43.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	16.92	0.00	4.23	7.40	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.83	9.96	1.39	1.31	0.57	0.24	0.16
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.76	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.64	8.90	0.76	1.80	0.85	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	14.76	17.82	0.79	1.48	0.91	0.11	0.00
Keratocytes, donor1	11527-119I6	5.50	5.85	0.69	0.00	1.72	0.00	0.00
Keratocytes, donor2	11607-120I5	5.86	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	7.31	9.29	1.19	1.98	0.40	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	15.39	2.20	4.40	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	5.39	3.24	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.96	10.61	2.19	1.04	1.50	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	11.71	12.82	2.12	1.31	0.40	0.71	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.66	4.39	1.07	0.24	0.36	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.07	1.95	0.56	0.56	0.28	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.96	8.50	0.31	0.63	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	2.69	0.00	0.54	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.84	3.15	0.32	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.18	1.62	0.22	0.22	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.21	6.16	1.64	0.00	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.53	2.28	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.93	4.22	0.70	0.28	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	4.35	1.19	0.40	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	3.68	0.19	0.19	0.78	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.04	1.67	0.37	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	2.79	0.00	0.35	1.05	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	3.34	0.48	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.12	3.57	0.41	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.24	2.77	3.08	0.31	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	2.81	0.31	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	3.66	0.18	0.18	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	3.62	0.99	0.66	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	1.46	0.59	0.59	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	2.74	0.00	0.00	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	4.85	0.48	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.77	2.42	0.81	0.27	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.36	3.48	0.61	0.61	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	2.07	1.04	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.63	7.12	0.84	0.84	0.84	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.77	3.31	0.45	0.60	0.45	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	1.38	0.69	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	2.82	0.56	0.19	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.92	2.01	0.21	0.00	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	7.27	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	2.32	0.33	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.22	2.60	0.62	0.12	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.59	5.55	2.22	1.11	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.72	5.19	0.74	0.49	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.26	2.89	0.55	0.27	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.72	8.68	1.93	1.29	1.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.48	4.87	1.22	0.30	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.56	7.70	0.56	0.70	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	2.49	1.07	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	1.94	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	1.71	0.31	0.16	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.37	3.58	0.36	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.57	4.57	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.59	1.41	0.00	0.00	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.13	3.59	1.11	0.25	0.50	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.82	2.31	0.77	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	2.98	0.60	0.60	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	4.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.90	1.53	0.00	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	2.23	0.74	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.31	6.77	0.00	0.85	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	5.63	0.70	0.00	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	5.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	5.15	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	5.95	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.24	2.49	1.36	0.68	0.68	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.67	5.82	0.29	0.87	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	4.50	3.15	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.54	6.23	1.63	0.54	1.08	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	2.57	1.03	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.53	7.41	2.12	0.71	2.47	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	4.00	1.33	2.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	4.08	0.51	1.53	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.67	8.80	1.07	0.53	0.27	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.34	5.48	2.08	0.57	2.08	0.76	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	6.14	1.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	15.49	4.08	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.58	8.33	0.62	1.67	1.25	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.45	8.41	1.12	0.56	1.40	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	7.21	2.06	1.03	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.16	7.84	1.45	0.87	0.87	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.26	5.98	1.20	0.60	0.90	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	4.43	0.55	2.21	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	9.19	3.53	1.41	0.71	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.91	4.06	3.32	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	6.91	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	5.76	0.38	1.15	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	2.26	0.57	0.00	2.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	4.10	0.00	1.64	0.00	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.78	5.87	0.45	0.45	1.36	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	9.34	5.03	0.72	0.72	2.15	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	3.73	2.24	0.75	2.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.55	4.46	1.49	0.37	0.74	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	5.17	0.86	0.43	0.86	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	14.56	5.99	2.57	0.00	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.33	5.66	1.00	0.33	0.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	2.41	0.00	0.00	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	2.84	0.00	0.71	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	3.09	0.69	0.34	0.69	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.12	3.76	1.07	0.00	2.15	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	2.69	0.67	0.00	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.48	7.41	1.85	1.11	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	4.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.60	8.40	2.00	2.00	2.00	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	5.81	0.00	0.73	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	4.60	0.00	0.00	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	4.44	1.97	0.49	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	5.65	0.00	0.94	0.94	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.05	6.03	1.01	0.50	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	6.31	0.90	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	6.88	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	4.90	1.78	1.34	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.99	6.26	0.78	0.78	1.17	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	4.62	1.32	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.53	3.63	3.11	0.00	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	11.81	6.13	1.31	0.88	1.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	5.03	1.68	1.12	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	10.60	3.53	0.88	1.32	1.32	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.49	5.40	1.93	1.16	1.54	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.67	6.58	2.03	1.01	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.09	5.29	1.44	0.96	1.44	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	6.36	0.80	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	9.11	2.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	7.61	2.08	1.38	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	9.12	1.14	1.14	1.14	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.81	9.81	1.55	1.55	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.86	3.63	1.21	0.60	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.56	5.07	1.90	0.00	1.27	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.13	9.06	2.13	1.07	3.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.62	3.45	2.87	0.00	2.87	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	10.80	6.17	1.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8.49	10.61	0.00	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.65	2.27	1.13	0.00	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.57	5.82	0.42	0.42	1.66	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	5.48	0.78	0.00	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	4.18	1.67	0.84	0.84	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.69	6.04	0.46	0.46	0.93	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	0.67	0.00	0.67	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.42	4.81	1.60	0.53	2.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.51	5.25	1.21	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	9.18	4.59	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	7.11	1.78	1.78	0.00	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	2.85	0.57	0.57	1.71	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	6.14	1.53	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	4.92	0.55	0.55	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.80	3.12	0.89	0.00	2.23	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.92	5.20	1.04	0.26	1.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	5.97	1.33	1.99	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	12.47	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.84	17.78	2.28	2.51	0.68	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	17.80	9.54	2.20	1.84	0.92	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	26.61	9.57	1.18	2.23	1.05	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	6.90	2.12	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.62	11.57	1.74	0.95	0.48	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	15.43	6.81	1.25	2.22	0.69	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	22.12	9.96	1.30	2.39	0.10	0.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	16.79	5.79	1.16	1.16	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.24	1.00	1.00	0.00	0.50	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	51.52	8.14	48.13	2.03	1.36	0.68	85.42
Mast cell, donor1	11563-120D6	47.26	15.36	3.89	2.60	1.84	1.62	0.43
Mast cell, donor2	11565-120D8	62.70	22.88	5.05	1.78	0.00	1.19	0.89
Mast cell, donor3	11566-120D9	70.46	25.89	7.65	1.80	0.90	1.13	1.13
Mast cell, donor4	11567-120E1	71.62	22.16	5.14	2.84	1.06	1.24	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	60.99	16.97	3.33	2.44	3.22	1.11	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	69.46	13.42	9.34	1.17	1.75	0.58	7.00
Mast cell, expanded, donor5	11939-126A4	33.27	13.88	2.18	1.49	1.03	0.92	0.11
Mast cell, expanded, donor8	11941-126A6	103.43	27.78	2.18	3.01	1.34	2.85	0.50
Melanocyte - dark, donor1	11502-119F8	15.12	4.78	1.29	0.60	0.60	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	5.88	4.15	1.38	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	6.23	11.59	0.58	1.16	0.29	0.22	0.00
Melanocyte - light, donor1	11274-116H5	4.23	7.05	0.00	0.24	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	3.41	3.41	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	0.87	0.87	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.10	7.18	0.94	0.73	0.52	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	5.11	5.92	0.54	0.27	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	5.09	13.12	0.80	0.27	0.80	0.80	0.00
Meningeal Cells, donor1	11493-119E8	7.57	9.18	0.62	0.50	0.50	0.00	0.00
Meningeal Cells, donor2	11573-120E7	9.24	7.48	0.44	1.32	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	10.43	8.64	1.55	0.41	0.41	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.41	9.41	1.14	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.98	10.77	1.61	1.31	0.30	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	5.74	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.44	11.65	2.96	0.85	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	6.53	1.01	0.50	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.27	2.64	0.44	0.66	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	3.65	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.50	4.30	0.20	0.20	0.61	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.43	6.23	0.69	0.14	0.00	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	2.60	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.16	6.58	1.18	0.66	0.79	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	2.97	0.59	0.00	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	9.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	5.76	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	3.90	5.67	0.71	0.35	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.26	5.00	1.25	0.63	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	1.45	2.18	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	7.96	5.04	1.59	0.00	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	5.51	3.50	4.00	0.00	0.50	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	11.92	5.64	4.26	0.72	0.79	0.14	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	43.21	52.66	1.35	6.75	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.37	12.81	0.99	1.97	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.91	9.42	1.47	2.65	0.59	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	24.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.36	6.82	0.93	0.93	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.28	7.26	1.04	2.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	37.06	0.00	2.32	2.32	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	14.01	11.01	1.50	1.75	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.60	18.15	2.79	3.26	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	77.86	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.96	8.33	1.02	1.22	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	16.63	9.90	3.17	1.98	1.19	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	25.65	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	6.19	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.92	4.94	1.14	1.14	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	14.47	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.49	5.52	1.27	0.42	0.85	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	14.73	0.92	2.76	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.35	8.05	0.60	0.89	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	23.47	0.00	10.06	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.27	2.76	0.00	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.12	4.52	0.24	0.95	0.00	0.24	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	6.63	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.45	5.76	1.15	0.92	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.52	5.05	0.21	1.68	0.63	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.54	5.91	0.61	2.45	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.94	5.79	0.64	1.50	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.45	5.56	0.22	2.67	1.33	0.00	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	3.94	0.66	0.66	0.44	0.00	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	7.60	1.01	3.04	0.51	0.00	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	13.26	0.00	4.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.96	7.34	1.36	2.17	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.12	6.18	1.47	1.47	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	20.72	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.84	2.40	0.96	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.81	4.40	1.20	1.20	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	24.68	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	5.01	1.00	1.00	1.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	24.46	0.00	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.51	5.26	0.88	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	13.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	32.02	20.49	1.28	3.20	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.67	5.45	0.25	1.24	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	4.87	1.39	2.78	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	24.31	0.00	15.47	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	3.76	0.34	1.03	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	6.13	0.00	4.38	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	38.35	22.02	0.36	4.97	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.62	7.57	0.28	1.40	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	7.07	1.66	1.25	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.71	15.73	0.00	3.50	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	9.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.45	7.51	0.83	2.50	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	57.75	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	8.31	0.92	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	11.38	1.14	1.71	0.57	0.57	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.08	14.09	0.69	3.18	0.69	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	5.18	0.52	0.26	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	23.59	9.44	1.72	4.29	0.43	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	37.48	28.58	0.64	6.99	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.01	11.48	0.53	3.47	0.53	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.74	7.48	1.20	1.80	0.60	0.00	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.01	11.58	1.13	3.81	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.83	4.14	0.00	1.27	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.53	6.19	0.66	3.32	0.66	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	24.65	24.27	0.76	7.58	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.92	9.38	0.57	1.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.78	8.85	1.72	2.95	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	33.89	0.65	7.82	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.05	13.53	2.06	2.06	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.10	13.26	1.73	2.88	1.15	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.98	23.49	1.24	2.06	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	15.19	1.19	1.79	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	5.35	1.78	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.86	10.84	2.30	1.64	0.33	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	6.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.20	9.09	0.59	2.17	0.59	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	14.90	4.66	4.66	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.39	12.77	1.88	2.25	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.06	7.72	0.80	1.60	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.73	5.99	0.79	1.24	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	8.84	0.74	1.47	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.63	9.89	0.73	2.56	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	20.22	0.00	3.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	7.48	0.53	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	7.07	0.00	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	6.32	1.69	2.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	2.72	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	3.18	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	2.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	7.55	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	22.84	0.00	17.13	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	19.57	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	9.50	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.32	9.69	1.08	1.29	0.65	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.88	12.54	0.00	1.05	0.52	1.57	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	10.68	1.33	3.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.77	9.18	0.83	1.25	1.67	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	44.49	21.30	1.52	4.94	1.14	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	28.73	1.60	6.38	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	4.08	0.68	2.72	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	16.54	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.49	3.35	1.67	1.26	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.83	9.53	1.63	2.09	0.70	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.05	12.16	0.54	2.70	1.08	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.88	20.18	1.47	1.05	1.47	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	10.92	0.50	0.50	0.50	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.59	10.56	1.62	2.98	0.54	1.62	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.24	6.57	2.49	1.13	0.68	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.29	9.80	0.82	1.63	0.65	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.93	16.77	1.09	0.73	0.55	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	6.90	0.53	1.59	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	10.81	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	30.52	23.63	2.30	5.25	0.33	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.45	7.81	2.28	2.11	0.81	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.29	25.75	1.59	3.53	2.65	0.88	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	3.52	2.11	2.81	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	8.73	1.84	2.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.32	8.68	1.61	0.64	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.52	20.69	5.17	4.14	0.69	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	27.81	12.64	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.59	28.07	1.78	3.79	1.78	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	5.50	0.85	1.69	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.29	12.34	1.66	1.19	0.47	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.30	10.30	1.72	1.29	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	18.06	18.06	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	14.33	1.00	1.67	1.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.17	31.56	1.80	4.96	0.90	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	7.14	1.98	2.38	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	7.43	0.93	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.08	9.08	1.89	1.14	1.51	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.08	9.45	1.63	4.24	1.30	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	24.40	0.00	3.49	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	28.04	2.26	3.62	1.81	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	8.82	0.88	2.65	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	11.30	0.00	0.66	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	11.91	0.50	1.98	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	12.25	1.15	1.15	1.15	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.75	10.28	1.81	0.91	0.30	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.17	23.65	2.43	2.65	0.88	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	10.16	2.03	2.03	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	30.66	10.22	5.11	0.00	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	10.97	2.44	0.00	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.27	11.33	0.94	2.83	1.57	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.44	14.22	0.61	2.12	1.51	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	7.91	0.79	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	37.41	34.01	6.80	3.40	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	15.17	10.12	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	6.83	6.21	0.87	1.12	0.12	0.25	0.12
Myoblast, donor2	11322-117D8	8.82	7.67	1.15	1.15	0.38	0.38	0.38
Myoblast, donor3	11398-118D3	8.41	9.59	1.68	1.85	0.67	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	28.17	17.80	5.40	1.02	0.88	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	81.80	28.29	8.30	4.61	1.54	0.31	2.46
Natural Killer Cells, donor2	11311-117C6	91.07	27.14	6.33	3.92	0.90	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	87.98	21.53	8.10	6.99	1.10	0.18	0.55
Neural stem cells, donor1	11275-116H6	22.14	65.33	13.79	3.99	3.27	3.27	1.81
Neural stem cells, donor2	11352-117H2	9.63	34.66	5.78	3.85	1.93	0.00	0.00
Neurons, donor1	11494-119E9	9.10	14.79	5.69	0.00	0.00	1.14	0.00
Neurons, donor2	11574-120E8	3.96	10.35	1.98	1.10	0.66	0.00	0.00
Neurons, donor3	11655-122E8	16.44	13.15	0.00	2.47	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	62.18	12.06	1.86	1.86	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	55.08	11.60	2.90	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	134.39	25.66	3.67	7.94	1.22	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	8.91	9.97	2.26	1.07	0.47	0.71	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	4.56	10.74	0.98	0.33	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	5.82	4.61	1.40	0.40	0.20	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	12.94	16.11	2.34	2.62	1.51	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	18.09	12.45	2.46	1.30	0.87	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	21.45	14.42	4.43	2.95	1.82	0.45	0.45
Olfactory epithelial cells, donor4	11936-126A1	18.21	16.17	3.41	1.75	1.66	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	9.03	1.20	1.81	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	3.83	5.74	0.64	0.43	0.21	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	2.29	8.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	7.45	1.86	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	1.95	1.37	0.20	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	5.62	8.43	1.40	0.70	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	7.46	4.98	0.53	0.18	0.71	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	12.64	8.26	2.11	0.67	0.59	0.42	0.34
Pericytes, donor1	11491-119E6	2.89	4.12	0.11	0.00	0.11	0.22	0.00
Pericytes, donor2	11571-120E5	2.94	4.75	0.45	0.23	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	4.68	1.83	0.00	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	8.59	6.67	0.57	0.23	0.34	0.23	0.00
Perineurial Cells, donor2	11579-120F4	12.42	5.80	2.21	1.01	0.28	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	106.78	54.19	7.65	8.29	1.91	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	69.54	25.71	4.65	5.88	0.98	1.47	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	84.12	30.02	7.76	6.86	2.20	0.65	0.78
Placental Epithelial Cells, donor1	11278-116H9	3.83	1.20	0.72	0.72	0.00	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	3.33	5.54	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.68	0.98	0.00	0.20	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.70	6.01	0.95	1.58	0.63	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	12.76	13.13	1.69	1.69	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.79	12.27	2.22	1.31	0.39	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	10.58	9.46	2.93	1.58	0.23	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	17.16	15.02	1.49	3.52	0.64	0.43	0.64
Preadipocyte - omental, donor2	11329-117E6	12.66	15.28	2.18	2.62	0.00	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	15.61	11.03	2.86	2.86	0.86	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	3.94	7.87	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	4.30	1.54	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	13.63	8.15	1.77	0.53	0.53	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.13	7.15	0.85	0.85	0.34	0.68	0.17
Preadipocyte - visceral, donor1	11280-116I2	12.39	10.34	2.14	1.30	0.56	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	12.89	11.04	2.30	1.38	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	8.57	4.60	1.36	0.31	0.31	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.29	18.71	5.43	4.07	1.36	1.36	0.30
Prostate Epithelial Cells, donor2	11331-117E8	12.59	6.91	0.95	0.41	0.95	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	15.62	11.57	0.55	2.14	1.16	0.24	0.00
Prostate Stromal Cells, donor1	11254-116F3	8.77	5.81	2.62	0.80	0.46	0.57	0.46
Prostate Stromal Cells, donor2	11332-117E9	13.27	9.68	3.23	0.90	0.36	0.90	0.36
Prostate Stromal Cells, donor3	11405-118E1	14.49	13.03	6.26	2.71	1.15	0.42	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	4.01	0.73	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.66	7.14	0.49	0.62	0.62	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	3.04	4.57	0.51	0.00	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	1.42	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	12.17	8.05	1.06	0.85	1.16	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	5.45	0.68	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.70	5.53	0.27	0.40	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	17.32	10.88	1.33	0.67	0.67	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	3.99	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.30	3.52	0.22	0.22	0.88	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	4.39	0.63	0.63	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.66	1.66	0.00	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	6.17	4.56	0.54	0.00	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.80	3.37	0.00	1.69	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.82	3.86	0.19	0.58	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.48	8.82	0.26	0.52	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.55	5.40	0.85	0.28	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	5.15	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	5.02	14.55	1.76	2.51	2.01	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.18	26.33	4.41	5.08	3.07	1.47	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	19.65	9.83	1.79	0.89	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.07	6.05	1.10	0.00	0.55	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	32.48	19.14	2.90	4.06	1.74	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.44	15.47	5.20	1.69	1.95	1.56	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.87	12.61	3.08	1.39	3.28	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.75	13.83	4.24	1.45	2.45	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.36	8.93	4.09	0.87	1.49	0.99	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.70	11.54	1.98	0.82	2.33	0.58	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.97	18.03	3.24	0.46	4.16	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.17	10.95	2.60	0.82	2.60	1.23	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.94	8.77	2.87	1.66	3.63	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.81	13.98	3.76	2.15	1.61	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.50	9.90	3.01	2.01	1.58	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.74	10.09	2.90	1.18	2.47	0.86	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.46	15.27	3.32	1.33	3.32	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	19.12	11.66	2.87	0.96	2.49	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.76	13.04	3.35	1.77	3.54	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.51	19.54	4.51	1.69	3.01	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.88	14.60	4.91	1.99	2.79	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.36	13.82	3.70	1.75	3.11	1.46	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.21	12.99	4.96	0.95	2.86	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.65	9.08	3.20	0.96	1.71	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.82	11.77	2.80	1.40	3.08	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.00	16.24	3.59	1.71	3.76	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.43	14.22	3.46	0.55	4.01	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.62	12.14	3.56	1.23	4.05	1.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.63	12.09	2.82	2.15	2.82	1.07	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.44	8.73	3.54	0.71	1.42	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.45	13.89	4.17	0.79	2.38	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.30	11.93	3.98	0.94	4.44	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.38	7.88	2.90	1.04	1.66	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.01	15.71	3.10	1.33	2.88	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.99	11.28	2.72	1.67	2.92	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.38	11.84	3.63	0.67	3.77	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.88	16.69	4.94	1.87	3.58	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.12	13.50	5.21	1.74	5.01	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	18.05	9.63	4.47	0.52	2.24	1.03	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.43	12.62	4.80	1.92	4.12	1.10	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.57	15.27	3.94	1.31	2.30	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.26	9.71	4.43	0.68	1.87	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.90	11.54	3.85	0.89	2.66	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.52	15.73	3.20	0.80	2.67	2.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.39	16.32	4.15	1.52	1.94	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.91	9.05	2.14	0.95	2.38	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	35.07	23.38	2.82	1.61	7.05	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	14.79	9.70	1.51	1.13	2.54	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.20	12.93	3.84	1.05	4.54	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.13	13.30	5.14	1.81	3.63	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.05	9.79	2.08	0.73	0.86	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.46	38.28	7.13	4.37	4.37	2.04	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.64	7.30	3.04	1.83	1.22	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.37	8.44	2.41	0.00	1.21	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.24	12.44	2.49	0.90	1.36	2.04	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.15	14.08	5.09	1.80	4.79	1.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.32	10.27	2.24	0.94	0.35	2.13	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.40	10.25	2.77	1.71	1.28	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	26.44	15.63	3.00	1.80	0.60	1.20	0.00
Schwann Cells, donor1	11498-119F4	3.20	2.44	0.00	0.19	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.89	3.94	0.66	0.66	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	8.76	8.76	0.00	1.10	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	7.81	7.35	0.46	0.46	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	3.09	4.74	0.41	0.21	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	3.31	3.31	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	8.47	8.47	0.00	5.65	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	6.51	8.27	1.50	0.18	0.79	0.62	0.00
Skeletal Muscle Cells, donor2	11358-117H8	1.45	2.17	0.72	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	1.67	3.34	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	8.64	6.76	0.94	0.63	0.31	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	6.24	7.28	0.89	0.89	0.30	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	10.16	8.46	1.54	1.23	0.62	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	12.47	12.85	1.01	1.39	0.00	0.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.56	9.70	1.43	1.00	0.29	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.91	11.91	1.98	0.79	0.40	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.32	7.08	1.35	0.42	0.17	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1.45	4.34	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.38	1.79	0.55	0.14	0.41	0.14	0.00
Skin - palm, donor1	10286-104F7	72.52	29.55	2.69	8.06	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.23	4.04	1.30	0.72	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	59.71	28.63	2.45	5.73	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.52	4.67	0.91	1.43	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	15.01	8.76	0.97	1.11	0.14	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	26.87	12.94	2.53	1.97	0.84	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	83.10	35.10	5.07	8.03	2.54	1.90	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	30.28	16.19	1.12	4.87	2.17	0.45	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.02	7.71	1.54	0.31	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.78	10.89	1.56	0.89	0.22	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	2.35	5.88	0.59	1.76	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.98	8.62	0.66	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.15	1.58	0.00	0.00	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	3.86	9.27	0.77	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	7.01	0.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.59	4.13	0.40	0.40	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.31	8.20	0.66	0.44	0.89	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.17	5.51	0.77	0.51	0.13	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.86	4.56	0.98	0.33	0.65	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	6.79	10.63	2.07	0.89	0.89	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.69	6.83	1.99	1.00	0.57	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.79	2.11	0.16	0.16	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	14.31	1.22	0.61	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.55	6.31	0.76	1.01	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	36.72	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	1.43	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.78	7.37	1.77	0.59	0.29	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	6.03	5.81	1.29	0.86	0.00	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.45	6.19	1.36	0.52	0.63	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.57	2.17	0.31	0.62	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	3.89	2.99	1.20	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.71	2.39	0.00	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	7.30	6.60	1.41	0.55	0.16	0.63	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.46	12.58	1.51	2.11	0.30	0.60	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.38	6.14	0.46	1.37	0.46	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	3.02	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8.48	6.36	0.79	0.26	0.00	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.65	9.19	2.66	0.53	0.67	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.65	14.15	3.38	2.50	0.63	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	9.39	2.03	0.25	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.50	6.48	1.81	0.90	0.75	0.60	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	3.00	0.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	59.44	9.05	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	4.65	1.40	0.93	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.02	4.04	1.01	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.70	4.70	0.31	0.31	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	2.06	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.16	7.41	1.83	0.58	0.67	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	8.88	0.47	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.73	3.02	0.58	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.33	2.55	1.02	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.44	0.56	0.38	0.38	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.94	6.15	0.70	0.56	0.28	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	6.62	4.69	0.59	0.84	0.25	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	3.81	0.48	0.95	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.40	2.20	0.24	0.73	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.69	5.08	2.65	0.88	0.66	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.39	2.63	0.88	0.59	0.59	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.75	17.49	1.55	2.72	0.97	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.64	10.84	1.32	1.59	0.79	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.27	8.93	2.98	1.49	0.74	1.12	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.53	16.89	3.95	5.39	1.44	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	6.81	7.10	1.14	0.57	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.48	9.85	0.39	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.14	13.21	2.29	2.79	1.02	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	14.38	30.75	1.60	2.00	1.60	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	17.14	1.67	3.34	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	10.54	0.92	1.83	0.46	0.92	0.00
Synoviocyte, donor1	11291-117A4	5.72	8.08	0.67	0.67	0.17	0.67	0.17
Synoviocyte, donor2	11368-117I9	7.21	9.05	2.18	1.01	1.51	0.34	0.84
Synoviocyte, donor3	11440-118H9	6.93	8.94	0.45	0.89	0.67	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	3.57	2.86	0.36	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	5.95	1.98	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.48	7.41	0.23	0.93	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.90	6.74	0.50	1.22	0.29	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	1.55	0.77	1.55	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	2.29	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.87	29.03	4.31	4.18	2.71	0.49	0.25
Urethra, donor2	10319-105A4	113.30	41.36	5.40	7.19	3.60	1.80	1.80
Urothelial Cells, donor1	11520-119H8	4.52	1.86	0.00	0.00	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.41	2.40	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.90	2.29	0.00	0.69	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	23.18	10.25	0.89	3.12	0.67	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	95.21	66.73	1.78	8.01	2.67	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	90.07	55.75	2.86	1.43	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	91.04	36.96	4.79	10.27	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	76.79	47.17	4.82	4.13	1.38	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.91	51.13	4.65	5.23	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	83.30	55.19	5.21	5.21	1.04	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	91.78	52.31	6.42	6.42	5.51	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	83.07	36.52	7.30	10.04	4.56	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.52	14.80	5.67	1.48	2.22	0.74	0.12
Wilms' tumor cell line:HFWT	10597-108E3	24.64	32.56	3.52	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.90	8.10	1.12	1.96	2.23	0.28	0.00
achilles tendon, donor2	10292-104G4	20.67	16.53	2.07	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	46.91	30.85	5.35	4.59	1.78	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	33.90	22.06	3.71	1.63	1.63	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	35.61	36.09	11.99	4.87	2.85	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	24.76	17.96	5.71	4.08	0.82	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.36	14.90	11.24	0.84	1.12	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.87	16.71	11.84	3.60	1.06	0.63	2.96
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	112.15	35.66	12.79	2.18	4.63	2.18	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.25	34.81	14.10	0.88	1.76	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	13.88	7.35	1.63	1.23	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.99	24.46	13.59	3.11	2.33	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	23.55	9.75	6.26	0.92	1.66	0.92	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	109.21	19.50	19.50	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.51	11.15	8.60	0.46	0.46	1.16	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.94	16.31	2.59	0.26	3.62	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	21.33	12.57	2.63	0.88	1.46	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	43.22	22.77	3.72	1.39	1.39	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	25.50	22.21	4.52	2.06	1.23	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.45	10.74	2.15	0.92	0.92	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	27.31	11.95	0.43	1.71	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.17	8.19	0.91	0.91	0.91	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.01	13.72	2.41	0.96	1.93	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.04	18.71	2.90	2.00	0.45	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	25.68	30.02	5.00	2.00	3.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	78.04	61.32	11.15	13.01	7.43	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.39	14.69	2.64	1.51	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.54	29.22	17.45	3.05	3.05	2.62	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	56.23	5.62	11.25	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	44.98	28.02	1.88	2.83	2.83	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	22.96	19.08	1.71	2.48	1.09	0.93	0.31
adipose, donor1	10184-103D4	20.52	41.64	9.97	4.10	1.17	1.76	1.17
adipose, donor2	10185-103D5	21.09	54.34	3.24	3.65	6.08	0.81	0.00
adipose, donor3	10186-103D6	19.60	46.56	11.16	5.45	1.91	0.82	1.36
adipose, donor4	10187-103D7	17.34	71.07	18.20	3.47	2.60	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.98	30.30	1.58	0.79	4.10	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	21.83	18.19	0.00	3.64	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	17.34	12.67	1.07	0.67	1.60	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	14.29	10.72	2.14	1.07	2.14	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	22.03	9.27	0.70	1.62	2.09	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	17.24	10.82	1.69	0.68	1.01	1.69	0.00
amniotic membrane cells, donor3	12237-129G5	23.27	8.25	2.06	0.88	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	21.34	55.73	4.74	3.56	9.49	0.00	0.00
amygdala, adult, donor10252	10151-102I7	37.31	58.60	3.45	6.08	10.54	1.22	0.41
amygdala, newborn, donor10223	10360-105E9	14.52	39.38	2.90	6.13	2.58	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	19.86	19.35	1.91	1.91	2.04	1.40	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.77	7.28	3.09	0.88	0.88	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	40.08	32.74	6.01	4.01	3.67	1.34	0.00
aorta, adult, pool1	10052-101G7	24.52	18.24	2.55	2.55	4.12	0.39	0.59
appendix, adult	10189-103D9	113.72	41.14	6.99	5.43	2.33	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.86	22.36	4.13	0.00	2.41	0.00	0.00
artery, adult	10190-103E1	5.43	16.30	4.08	1.36	5.43	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	14.78	15.50	3.48	0.87	0.58	1.16	0.14
b cell line:RPMI1788	10427-106D4	42.08	33.01	6.99	6.25	4.91	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.16	11.38	1.94	2.22	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.44	10.52	4.47	2.38	0.69	0.89	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	26.61	15.73	2.01	2.01	0.50	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	12.86	1.12	1.12	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	35.63	29.77	4.67	3.91	5.98	2.06	0.98
blood, adult, pool1	10053-101G8	115.16	17.72	2.21	6.64	11.07	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	18.84	2.57	3.43	0.86	0.86	0.00
bone marrow, adult	10192-103E3	15.52	18.90	2.02	3.37	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	21.53	34.85	2.05	0.00	7.18	0.00	0.00
brain, adult, pool1	10012-101C3	19.38	40.87	2.12	4.12	8.35	1.67	0.89
brain, fetal, pool1	10085-102B4	2.67	29.39	0.00	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.00	26.43	5.62	3.30	2.64	1.98	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.21	34.70	3.12	6.49	6.37	0.62	0.12
breast, adult, donor1	10080-102A8	56.19	15.78	2.53	1.26	3.79	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.96	6.99	1.91	1.52	1.02	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	37.72	28.14	3.71	3.40	3.40	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.03	8.98	0.46	0.46	0.46	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.18	15.74	2.42	2.18	0.24	0.73	0.48
carcinoid cell line:NCI-H1770	10703-109H1	10.34	40.90	0.47	2.82	2.35	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	34.02	32.92	3.94	7.33	2.08	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	14.26	16.80	0.95	1.58	2.85	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.02	49.78	8.78	1.33	2.93	2.40	1.06
caudate nucleus - adult, donor10196	10177-103C6	26.48	48.36	4.61	2.30	3.45	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	25.27	46.01	3.68	3.85	5.52	1.34	0.50
caudate nucleus, adult, donor10258	10379-105H1	14.52	56.55	1.53	2.29	3.06	2.29	3.06
caudate nucleus, newborn, donor10223	10354-105E3	16.85	30.03	4.03	1.83	1.10	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	43.70	52.44	0.00	5.83	52.44	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	41.63	60.00	4.91	2.56	23.91	1.49	0.21
cerebellum, adult, pool1	10083-102B2	22.77	19.32	1.72	3.10	3.45	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	23.25	29.89	6.64	0.83	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	18.66	33.53	3.53	4.79	2.02	2.27	1.26
cerebrospinal fluid, donor2	10294-104G6	21.20	10.96	1.46	2.19	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.50	8.63	4.03	0.58	0.43	0.86	0.43
cervical cancer cell line:ME-180	10553-107I4	19.22	6.79	0.99	1.66	0.50	0.17	0.00
cervix, adult, pool1	10013-101C4	28.77	27.72	6.40	3.57	4.41	2.94	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.02	14.49	0.98	1.81	0.70	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	28.74	1.31	6.53	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	30.20	40.39	3.48	3.85	3.23	2.11	0.25
choriocarcinoma cell line:SCH	10785-110H2	11.46	7.76	0.25	0.74	1.48	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	19.92	31.78	1.19	3.56	1.66	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	21.94	7.41	1.71	2.85	0.57	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	17.00	10.44	0.99	1.69	0.50	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	32.97	9.34	1.65	0.00	0.55	2.20	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	11.11	9.09	0.00	0.00	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.70	11.53	6.92	1.34	1.73	0.77	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.49	11.19	3.59	2.11	0.63	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	29.53	33.38	6.68	2.05	4.11	0.51	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	34.35	38.70	7.98	2.66	3.63	0.48	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	33.39	28.10	7.33	3.26	5.29	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	42.99	44.17	14.13	2.94	2.94	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	49.26	21.89	8.86	2.87	2.87	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.80	6.17	0.91	0.23	1.14	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.04	16.14	2.95	1.39	0.87	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	21.78	17.21	3.84	3.29	0.18	0.92	0.37
colon carcinoma cell line:COLO-320	10420-106C6	11.02	33.45	4.56	1.14	4.18	0.76	0.38
colon, adult, donor1	10082-102B1	63.07	21.42	3.57	3.57	3.57	2.38	0.00
colon, adult, pool1	10014-101C5	39.72	27.14	5.88	3.53	2.00	1.53	0.35
colon, fetal, donor1	10070-101I7	90.84	30.90	5.56	4.33	2.47	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	242.93	132.92	27.50	18.33	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	23.37	14.87	1.27	2.12	0.42	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.49	12.07	1.21	1.96	0.91	0.30	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	17.77	10.72	1.97	1.27	0.56	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	12.05	27.86	1.33	2.21	6.74	0.55	0.44
cruciate ligament, donor2	10295-104G7	34.04	22.69	2.43	2.43	0.81	3.24	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	15.25	0.00	1.61	4.01	0.00	0.80
diencephalon, adult	10193-103E4	17.04	28.08	1.44	2.16	5.52	0.72	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	33.75	22.27	4.36	2.76	1.38	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.34	34.88	2.82	3.08	0.77	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.46	24.07	3.37	2.17	0.72	0.24	0.48
ductus deferens, adult	10196-103E7	52.33	25.91	6.48	3.99	2.99	4.98	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	40.33	2.88	1.44	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.05	28.69	5.89	5.15	0.74	0.74	2.21
dura mater, adult, donor1	10041-101F5	22.22	29.73	3.88	2.15	2.23	0.99	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	27.31	17.99	3.78	2.66	1.11	0.67	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.89	13.18	3.44	1.15	0.57	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	41.93	36.38	1.23	2.47	1.85	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	16.95	11.20	0.91	1.21	1.21	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.49	32.11	0.93	2.16	1.54	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	39.40	30.21	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	15.75	18.10	9.39	1.01	1.01	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.39	24.83	1.99	1.63	1.27	1.81	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.65	6.59	0.96	0.64	0.80	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	20.56	12.23	1.78	2.22	0.56	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.70	14.85	2.09	2.75	1.43	0.55	0.55
epididymis, adult	10197-103E8	25.75	32.86	3.98	2.30	2.09	2.30	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	32.64	33.53	7.81	3.90	3.02	1.24	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.44	9.44	3.54	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	16.51	10.35	2.10	0.79	0.52	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.01	14.66	2.26	1.18	1.38	1.08	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.66	8.85	2.24	0.90	1.23	0.22	0.11
esophagus, adult, pool1	10015-101C6	20.92	23.57	2.23	1.91	1.81	1.06	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	46.09	24.55	2.50	1.88	1.50	0.88	0.13
eye - muscle inferior rectus, donor1	10272-104E2	62.78	21.73	4.83	12.07	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	27.35	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	53.58	25.30	4.46	7.44	5.95	0.00	1.49
eye - muscle superior, donor2	10297-104G9	47.01	20.64	4.59	1.15	5.73	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	33.52	17.49	1.46	0.00	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	20.85	12.20	2.80	0.76	4.83	2.03	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	14.23	11.41	0.90	1.41	1.03	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.58	10.92	1.66	0.24	1.42	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	20.83	52.07	2.72	6.29	6.85	0.84	1.69
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	31.53	10.21	2.10	1.80	0.90	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	26.79	38.22	10.33	6.67	3.57	0.64	1.74
gall bladder, adult	10198-103E9	33.80	25.35	2.41	1.69	2.66	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	44.02	10.74	5.37	0.54	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	55.65	14.94	2.61	1.87	1.12	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.90	8.45	2.96	1.27	1.48	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	30.95	18.37	3.09	2.13	1.93	0.97	0.19
gastric cancer cell line:AZ521	10549-107H9	26.89	30.82	2.30	2.30	1.15	1.64	0.33
gastric cancer cell line:GSS	10560-108A2	26.54	28.37	0.92	0.92	3.66	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.24	26.04	5.03	7.08	2.28	1.14	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.88	9.64	0.57	1.38	1.26	0.23	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	35.69	18.33	5.18	1.54	1.68	0.84	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.19	16.96	2.00	2.49	0.75	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	15.52	26.70	5.07	2.85	1.69	1.16	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	18.82	25.00	6.18	3.23	1.69	1.26	0.28
glioblastoma cell line:T98G	10485-107A8	12.25	11.48	5.85	1.32	0.55	0.66	0.00
glioma cell line:GI-1	10413-106B8	13.77	12.59	4.39	2.64	0.29	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	31.34	28.43	1.46	0.00	7.29	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	28.31	22.21	0.98	1.71	13.18	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	2.74	21.91	4.11	0.00	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.66	24.51	2.13	2.66	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	183.54	139.49	12.24	31.81	4.89	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.08	17.60	5.76	3.52	0.32	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	9.64	31.68	8.72	0.92	0.92	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	9.60	31.09	4.57	1.83	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	8.37	21.90	5.80	1.29	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	34.49	5.75	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.86	32.92	8.23	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	8.83	35.31	4.41	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	19.54	10.63	2.30	1.72	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	22.12	13.15	3.89	0.90	0.90	1.79	0.60
heart - pulmonic valve, adult	10206-103F8	27.72	23.27	3.92	2.09	3.40	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	47.46	9.16	5.00	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	19.18	6.73	0.41	1.43	1.84	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	13.63	9.79	1.70	1.28	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	14.49	11.27	2.30	1.84	1.61	0.46	0.00
heart, fetal, pool1	10046-101G1	22.28	23.72	3.08	2.16	2.36	1.64	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.06	12.03	1.23	1.54	2.16	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	61.84	46.38	8.32	16.65	5.95	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	33.37	37.35	6.74	5.75	4.09	1.77	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	34.35	35.08	8.13	5.22	4.85	1.21	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.85	40.02	7.98	6.57	6.16	0.81	0.30
hepatoma cell line:Li-7	10484-107A7	12.90	12.90	3.78	1.89	0.33	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.39	14.47	6.63	1.51	1.71	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	26.50	52.05	1.89	6.62	6.62	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	36.33	45.11	4.29	3.06	9.39	1.63	0.61
hippocampus, adult, donor10258	10374-105G5	12.45	35.85	1.49	1.99	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	16.21	41.24	3.17	3.17	1.41	1.41	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.87	36.62	7.32	2.44	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.30	40.25	3.34	4.91	3.14	0.98	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.77	46.21	4.32	7.62	2.54	0.51	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.99	46.24	4.51	3.95	2.26	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.92	45.96	4.65	5.16	7.75	3.10	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.01	39.10	3.80	3.04	3.80	1.52	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.98	26.86	12.55	2.92	1.17	2.04	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.48	42.01	6.89	5.17	5.39	2.37	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.93	34.20	7.92	5.00	2.09	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.58	21.31	5.45	1.18	1.89	1.66	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	19.61	27.32	6.91	3.54	2.89	1.45	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.08	34.34	9.43	0.67	0.67	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.99	40.69	3.29	5.95	2.35	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.25	38.81	3.44	2.95	1.47	1.97	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	24.44	3.49	2.62	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	23.29	46.58	5.15	5.73	6.11	1.91	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.93	48.84	3.05	2.62	4.36	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.49	46.98	1.00	4.50	2.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.43	36.55	4.52	3.58	3.96	1.70	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	11.37	35.92	3.18	2.27	4.55	1.82	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.59	38.84	3.45	2.82	1.25	2.82	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.41	30.05	4.41	2.61	1.47	1.31	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.29	20.90	4.06	1.45	1.45	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	10.46	31.98	4.78	3.59	2.69	2.39	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.15	34.73	6.10	2.77	1.85	1.11	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.12	32.81	4.85	3.99	1.71	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	30.22	8.17	3.67	0.41	2.04	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.90	35.56	1.41	3.87	2.46	1.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.47	36.11	3.17	4.75	3.17	1.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.13	38.43	4.24	1.82	2.12	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.03	30.51	3.62	3.62	0.52	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	32.54	4.65	3.32	0.66	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4.62	15.39	6.67	2.31	0.51	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.46	15.08	5.62	1.28	0.77	1.53	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	30.29	1.51	3.03	0.76	3.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.75	24.53	2.69	3.02	0.67	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.35	44.44	5.55	3.86	3.38	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	17.83	41.45	5.79	4.90	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	33.66	11.22	4.88	2.44	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.64	47.37	4.28	4.28	4.58	1.83	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	26.03	13.01	3.25	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.54	30.45	3.31	3.31	1.65	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.34	32.84	4.93	3.83	2.74	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	8.69	29.67	5.43	1.81	1.81	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.25	24.91	5.34	2.14	1.78	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	36.99	3.58	1.19	0.00	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.36	32.10	10.70	2.57	0.95	2.17	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.62	22.90	7.54	2.16	1.35	1.08	0.27
immature langerhans cells, donor1	11904-125F5	20.34	7.99	1.94	0.97	0.48	0.00	1.21
immature langerhans cells, donor2	11905-125F6	15.84	12.67	2.38	3.17	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.01	56.78	3.03	6.62	6.81	0.95	1.80
keratoacanthoma cell line:HKA-1	10791-110H8	27.64	6.50	1.95	1.30	0.33	0.65	0.00
kidney, adult, pool1	10017-101C8	30.34	23.13	2.80	2.70	1.10	1.10	0.40
kidney, fetal, pool1	10045-101F9	21.93	20.65	3.75	2.12	1.84	1.13	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.58	21.45	8.81	2.70	2.13	0.99	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.60	7.33	0.83	0.55	1.52	0.83	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.33	17.98	2.57	3.30	1.47	0.55	0.00
left atrium, adult, donor1	10079-102A7	15.80	20.16	1.09	2.18	1.09	1.09	0.00
left ventricle, adult, donor1	10078-102A6	19.72	8.60	1.52	1.52	1.52	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	22.98	30.92	7.93	2.74	2.46	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	5.75	3.23	0.36	1.80	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	1.63	3.80	2.72	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	4.61	5.58	0.73	1.70	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	19.87	2.09	3.14	5.23	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	31.05	15.35	4.84	2.95	1.30	0.12	0.71
liposarcoma cell line:KMLS-1	10782-110G8	16.09	12.50	3.28	1.56	0.94	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	12.55	11.57	2.92	0.97	1.71	0.24	0.00
liver, adult, pool1	10018-101C9	19.93	20.42	1.13	4.05	0.65	1.13	0.32
liver, fetal, pool1	10086-102B5	15.99	12.23	1.88	0.94	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	40.39	35.44	2.62	5.69	11.96	1.90	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.62	21.59	0.92	2.03	9.60	0.74	0.92
locus coeruleus, adult, donor10258	10375-105G6	11.85	10.16	1.97	1.97	4.23	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	24.82	21.87	2.52	1.26	2.10	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	18.27	19.24	1.94	3.32	0.14	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	46.19	41.36	5.52	9.65	5.52	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	45.34	31.37	10.28	4.48	2.64	0.79	0.26
lung, adult, pool1	10019-101D1	32.96	16.07	2.72	2.48	1.65	1.06	0.95
lung, fetal, donor1	10068-101I5	48.23	35.96	7.71	2.28	1.14	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	75.15	19.70	4.58	5.50	3.67	1.37	0.00
lymph node, adult, donor1	10077-102A5	73.84	24.14	5.68	2.37	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	35.29	12.49	3.29	1.75	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	46.49	16.45	4.23	3.92	0.45	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	40.78	26.33	2.55	2.55	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	12.43	23.09	2.66	3.11	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	11.83	16.19	1.25	3.74	1.45	0.21	0.62
mature adipocyte, donor3	12233-129G1	9.48	18.02	1.66	2.61	0.71	1.42	0.24
mature adipocyte, donor4	12234-129G2	12.37	20.79	1.58	3.16	0.26	1.32	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	76.24	76.00	1.91	11.67	2.62	1.91	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	49.63	4.51	3.38	14.66	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	36.41	51.68	3.86	3.68	17.10	1.10	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	17.79	44.16	2.86	2.54	5.08	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	32.41	2.99	2.99	1.71	0.43	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	30.88	62.61	4.22	9.11	10.29	0.84	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	45.20	52.00	2.97	5.09	15.70	1.70	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	28.89	1.93	1.93	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	43.06	0.00	0.00	14.35	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	42.71	5.38	4.67	3.59	0.36	2.15
medulla oblongata - adult, donor10196	10174-103C3	26.61	25.96	1.95	3.24	3.89	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	28.64	23.84	2.94	2.01	10.06	1.86	0.62
medulla oblongata, adult, pool1	10038-101F2	15.67	26.45	1.39	2.53	5.71	0.73	0.08
medulla oblongata, newborn, donor10223	10361-105F1	14.93	14.58	2.78	0.69	3.47	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	21.48	62.22	19.93	2.44	5.31	1.99	0.89
medulloblastoma cell line:ONS-76	10759-110E3	18.46	11.00	1.22	2.32	0.73	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	19.12	12.94	1.58	1.72	0.72	1.01	0.14
melanoma cell line:G-361	10465-106H6	11.13	10.32	1.90	1.09	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	11.76	4.34	0.90	0.90	0.54	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	44.94	8.81	4.41	2.64	6.17	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	17.63	16.07	7.52	2.33	1.56	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.29	6.60	1.53	0.61	0.46	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.73	5.09	2.54	1.45	0.55	0.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.80	9.11	1.66	0.00	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.78	5.62	1.26	0.84	0.70	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.47	7.90	1.73	2.12	0.19	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	10.41	2.08	0.00	0.69	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.10	14.07	2.92	4.98	1.37	0.69	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.82	8.74	1.27	1.15	0.92	0.92	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.28	4.38	1.33	0.13	0.27	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.07	5.00	2.16	1.35	1.08	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.10	6.54	1.71	0.85	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	17.79	13.17	0.33	2.31	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.58	5.67	1.11	0.69	0.97	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	5.93	1.05	0.35	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.17	4.49	1.02	0.41	0.00	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.75	5.39	0.36	0.72	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.62	4.86	0.52	0.62	0.10	0.62	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.02	4.33	1.60	0.68	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.49	5.03	4.62	0.00	0.00	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.22	4.63	1.05	0.75	0.15	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.09	4.64	1.23	0.44	0.26	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.20	10.31	0.74	1.10	1.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.87	6.01	1.43	0.86	0.86	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	7.16	7.16	0.84	0.42	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.31	6.85	1.83	2.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.72	7.42	0.51	1.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.81	6.81	0.26	1.31	0.26	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	7.39	0.31	2.16	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.65	6.12	0.94	0.47	0.24	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.75	9.14	0.34	0.68	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.93	8.65	1.18	0.00	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	6.95	1.85	1.39	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.08	6.35	1.44	0.29	0.58	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.92	9.82	0.89	0.67	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.89	7.21	0.48	1.68	0.48	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	8.07	3.67	2.20	2.20	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.05	8.06	0.67	1.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	11.87	1.64	0.82	0.41	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.15	9.02	0.00	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.85	6.50	1.95	0.65	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	0.00	5.82	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	13.33	2.13	1.07	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	7.36	1.64	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	4.66	1.94	1.55	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	8.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	2.98	0.00	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	8.30	2.37	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	13.40	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	7.60	1.90	1.27	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	5.52	1.72	0.69	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	4.30	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	4.48	0.81	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	4.77	0.79	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	3.54	0.00	1.18	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.61	5.30	0.00	0.94	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	0.00	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	4.73	0.00	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	7.70	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	5.51	8.95	1.38	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2.47	5.94	1.48	1.48	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	2.24	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	5.72	1.91	3.18	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	5.24	1.21	0.40	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	9.71	1.21	0.61	1.21	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	36.15	4.52	4.52	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	5.77	1.65	2.47	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	5.75	1.19	0.40	0.20	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.49	4.22	1.95	0.32	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	1.02	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	44.88	1.55	3.87	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	27.88	37.09	1.65	2.13	5.91	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.16	11.82	5.33	0.70	1.16	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	15.10	12.64	2.36	0.82	0.21	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	5.45	5.22	0.91	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	16.87	8.31	2.44	2.44	0.73	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	15.50	5.98	2.21	0.22	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	20.76	7.36	4.99	0.79	1.31	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	13.62	8.85	2.89	1.53	1.02	0.34	0.51
mesothelioma cell line:Mero-84	10855-111F9	8.09	5.06	1.52	0.51	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	10.56	7.25	1.45	0.41	0.41	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	13.09	9.77	2.65	1.33	0.83	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	10.68	5.25	5.61	0.72	0.54	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	12.81	9.57	3.07	0.17	1.37	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	28.50	19.34	1.53	1.53	0.51	0.25	0.25
mesothelioma cell line:No36	10857-111G2	17.94	17.94	6.85	4.89	1.30	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	15.72	11.38	1.90	0.81	0.54	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	13.43	8.44	0.77	0.58	0.77	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	20.27	8.06	1.22	0.73	0.37	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	16.51	11.31	1.44	0.36	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.45	6.86	0.33	0.98	0.98	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.36	9.33	0.85	0.42	1.06	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.59	36.17	2.76	6.22	3.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.56	7.61	0.76	1.33	0.38	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	30.86	26.79	3.51	2.40	2.59	0.00	0.18
myeloma cell line:PCM6	10474-106I6	23.92	9.09	1.78	1.98	0.40	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	35.51	20.29	3.04	5.07	2.54	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.98	15.10	1.77	1.37	1.18	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.92	5.68	0.22	0.89	0.33	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.49	4.93	0.15	1.40	0.51	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	15.46	13.25	3.31	0.55	0.00	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	7.36	24.62	12.42	1.38	3.22	1.84	0.46
neuroblastoma cell line:NB-1	10539-107G8	12.35	23.76	12.35	1.87	0.75	2.25	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	12.65	17.29	0.84	2.32	1.48	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	10.25	26.09	11.37	1.68	3.73	1.86	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	24.43	31.08	4.03	3.08	1.66	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.05	23.44	2.85	2.22	0.63	0.95	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	6.84	17.31	3.62	2.01	0.81	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	24.79	3.81	1.91	1.27	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.63	10.11	1.06	3.19	1.06	0.27	0.00
neutrophil PMN, donor1	12133-128D9	297.50	59.50	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.66	61.39	3.89	5.58	5.07	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.01	8.81	12.01	3.20	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.34	8.34	1.60	0.96	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.82	9.72	2.63	1.84	0.26	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	18.65	42.56	3.09	3.84	6.66	1.22	1.59
occipital cortex - adult, donor10196	10172-103C1	28.85	53.57	2.06	6.18	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	53.67	55.01	2.42	4.29	20.40	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	13.83	36.76	2.91	4.37	2.91	0.36	1.09
occipital lobe, adult, donor1	10076-102A4	22.30	31.49	2.89	6.04	7.08	1.57	0.79
occipital lobe, fetal, donor1	10073-102A1	15.88	18.88	3.43	3.86	2.57	0.86	0.00
occipital pole, adult, pool1	10036-101E9	12.61	29.72	1.42	2.13	6.07	0.32	0.39
olfactory region, adult	10195-103E6	20.63	49.86	3.44	2.29	10.51	0.57	0.38
optic nerve, donor1	10277-104E7	44.02	56.03	0.00	10.01	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.86	25.97	2.96	2.96	1.37	0.80	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	11.27	23.08	1.37	2.34	2.75	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.41	9.99	2.37	1.52	1.52	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	25.64	13.40	4.97	1.50	0.23	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	17.64	16.17	2.65	1.76	0.59	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	58.86	74.75	3.74	11.21	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	9.12	17.39	1.48	0.64	0.64	0.21	0.21
ovary, adult, pool1	10020-101D2	21.40	19.92	6.29	2.10	1.92	2.10	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.85	9.17	0.92	1.28	2.02	0.18	0.00
pancreas, adult, donor1	10049-101G4	32.92	16.93	3.76	3.76	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	73.24	37.46	3.91	8.11	1.68	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	9.88	11.58	2.38	0.51	0.34	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.92	20.04	5.30	2.98	1.49	0.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	22.88	45.03	3.48	4.12	9.88	1.28	0.46
parietal cortex, adult, donor10258	10373-105G4	11.74	41.84	3.67	0.73	1.47	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	27.27	31.98	0.94	2.82	6.58	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	43.04	51.59	3.14	3.99	16.25	1.14	1.14
parietal lobe, adult, pool1	10034-101E7	18.68	44.85	2.29	4.14	9.61	0.18	0.70
parietal lobe, fetal, donor1	10072-101I9	24.25	54.31	6.79	5.82	4.85	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	16.08	35.89	2.99	6.36	2.62	0.75	1.50
parotid gland, adult	10199-103F1	25.28	12.33	1.85	2.47	1.85	2.47	0.00
penis, adult	10200-103F2	20.95	22.02	3.22	0.00	1.61	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.53	25.66	1.86	0.37	2.23	0.93	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.51	6.99	1.75	2.33	1.17	0.58	0.00
pineal gland - adult, donor10196	10179-103C8	42.57	45.15	0.00	2.58	20.64	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	49.15	24.87	1.78	1.78	7.70	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	14.42	35.74	0.00	1.88	6.27	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	23.27	54.64	3.04	3.04	3.04	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	78.18	68.80	9.90	5.73	7.82	2.61	0.52
pituitary gland, adult, donor10258	10378-105G9	20.43	40.01	2.55	1.70	5.11	1.70	0.00
placenta, adult, pool1	10021-101D3	38.06	33.22	3.66	3.76	2.58	0.97	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	45.82	29.13	4.63	7.28	3.31	0.53	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.28	26.77	5.29	1.40	1.25	0.62	0.00
pons, adult, pool1	10033-101E6	22.29	27.89	1.89	1.55	6.37	1.12	0.43
postcentral gyrus, adult, pool1	10032-101E5	12.38	33.39	1.13	2.96	5.32	0.52	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	110.84	79.47	14.64	20.91	0.00	4.18	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.63	15.59	0.58	1.89	1.89	0.15	0.44
prostate cancer cell line:PC-3	10439-106E7	26.68	18.88	4.54	2.00	0.73	1.63	0.00
prostate, adult, pool1	10022-101D4	31.74	22.13	4.81	2.27	2.72	1.90	0.54
putamen, adult, donor10196	10176-103C5	20.54	55.47	4.96	2.83	6.85	0.47	1.89
putamen, adult, donor10252	10152-102I8	13.73	23.53	3.92	1.96	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	25.13	5.46	1.09	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	15.46	49.29	2.17	4.11	3.87	1.21	0.72
putamen, newborn, donor10223	10365-105F5	29.24	18.74	3.00	2.25	3.75	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	45.68	15.42	1.45	2.33	0.87	0.29	0.00
rectum, fetal, donor1	10067-101I4	65.38	15.30	12.52	4.17	6.95	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.75	16.54	2.33	0.42	0.64	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.73	6.63	0.83	0.00	2.90	0.41	0.00
retina, adult, pool1	10030-101E3	20.48	27.73	1.79	1.99	5.17	1.59	0.30
retinoblastoma cell line:Y79	10475-106I7	15.33	50.40	6.75	5.98	3.64	1.82	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.43	15.61	3.57	1.72	1.84	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.68	40.21	23.06	3.66	1.41	2.53	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	16.67	30.31	3.79	0.76	3.03	0.00	0.00
salivary acinar cells, donor1	11771-123I7	19.75	11.49	2.59	2.27	0.49	1.13	0.49
salivary acinar cells, donor2	11772-123I8	19.96	12.53	2.75	2.07	0.96	0.83	0.28
salivary acinar cells, donor3	11773-123I9	72.16	40.39	5.30	3.97	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	16.59	21.16	2.29	1.14	2.86	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.71	14.50	0.93	1.35	0.67	0.76	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.05	14.93	0.59	1.18	0.82	0.35	0.12
seminal vesicle, adult	10201-103F3	64.55	43.91	8.47	4.23	3.17	4.76	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	44.70	22.35	6.56	3.40	1.94	0.49	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.03	4.78	0.25	1.26	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	13.05	9.03	0.00	0.00	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.91	16.12	1.75	0.94	0.67	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	17.35	13.82	1.66	2.54	0.88	0.55	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.39	15.74	4.77	2.58	0.90	1.03	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	26.25	30.50	0.71	4.26	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	12.59	17.03	1.56	3.60	1.92	0.72	0.12
skeletal muscle, fetal, donor1	10066-101I3	16.08	7.04	3.02	0.00	2.01	0.00	1.01
skin, adult, donor1	10074-102A2	47.50	20.36	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	34.09	16.41	3.79	2.52	1.26	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	21.35	4.67	2.33	5.34	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.56	40.98	2.84	5.67	2.52	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.79	24.48	0.77	1.73	0.77	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	47.31	33.62	5.27	4.29	2.14	1.48	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	16.41	51.95	4.02	4.02	17.05	0.64	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	25.28	20.27	3.27	1.74	0.65	0.65	0.22
small intestine, adult, pool1	10024-101D6	63.90	25.20	3.11	2.99	1.43	1.55	0.00
small intestine, fetal, donor1	10064-101I1	31.45	24.32	4.42	1.97	0.74	1.47	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	31.80	14.87	0.00	2.56	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	27.91	25.33	8.01	4.14	4.39	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	36.72	39.40	4.02	7.77	1.88	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	40.38	33.95	2.52	6.42	11.70	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	27.99	18.92	1.97	3.15	9.46	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	12.45	15.91	0.69	1.38	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	13.42	23.17	4.88	1.83	2.44	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	19.29	16.07	3.21	3.67	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.97	11.65	2.69	1.05	1.34	0.60	0.00
spleen, adult, pool1	10025-101D7	62.56	28.19	3.41	3.85	2.53	1.21	0.22
spleen, fetal, pool1	10044-101F8	32.02	17.80	1.59	1.99	1.19	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	37.26	21.94	5.80	2.90	2.38	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.18	10.63	2.47	2.09	1.14	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	30.05	16.77	1.75	0.70	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.29	7.04	1.56	0.78	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.59	12.61	3.04	2.14	0.45	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	19.06	19.06	11.86	1.27	1.27	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.88	20.31	2.96	0.85	1.69	0.42	0.42
stomach, fetal, donor1	10062-101H8	86.51	59.81	9.61	10.68	3.20	2.14	0.00
submaxillary gland, adult	10202-103F4	38.74	20.51	3.42	1.71	1.71	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.73	16.62	1.66	1.04	11.22	0.83	0.42
substantia nigra, adult, donor10258	10371-105G2	8.79	19.66	1.55	0.52	3.10	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	24.73	1.41	2.83	2.83	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	13.99	19.49	4.81	3.21	0.23	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	12.63	34.93	1.86	2.37	4.58	0.68	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	15.67	43.45	6.41	1.42	10.68	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.99	46.15	4.83	1.76	4.83	0.44	0.44
tenocyte, donor1	11763-123H8	8.38	11.52	0.70	0.70	0.70	1.40	0.35
tenocyte, donor2	11765-123I1	4.96	7.63	2.29	0.00	0.76	0.38	0.38
tenocyte, donor3	11768-123I4	5.56	7.04	0.74	0.74	0.37	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.96	38.75	8.67	1.53	2.38	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	21.12	19.58	5.55	2.93	1.70	0.77	0.00
teratocarcinoma cell line:PA-1	10807-111A6	18.75	31.77	9.45	3.10	0.62	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.86	14.73	4.44	1.40	1.27	0.63	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.07	70.72	14.75	2.27	5.29	4.54	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.79	18.87	10.58	2.51	0.11	1.53	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.57	19.22	18.57	1.63	0.98	0.33	0.00
testis, adult, pool1	10026-101D8	36.40	34.47	6.33	4.08	5.37	2.58	0.97
testis, adult, pool2	10096-102C6	55.93	32.48	4.96	2.26	8.57	1.80	0.00
thalamus - adult, donor10196	10168-103B6	58.51	47.47	0.00	4.42	7.73	0.00	0.00
thalamus, adult, donor10252	10154-103A1	26.57	27.66	1.09	1.41	9.69	1.41	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	50.81	1.54	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.97	33.10	1.98	3.62	3.46	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	41.42	24.16	1.73	6.33	2.88	0.58	1.15
throat, adult	10209-103G2	18.97	16.48	3.75	1.75	0.75	1.00	0.50
throat, fetal, donor1	10061-101H7	36.87	19.20	7.01	3.66	2.13	1.83	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	15.90	22.26	1.79	1.19	0.60	1.59	0.60
thymus, adult, pool1	10027-101D9	63.23	43.54	7.46	4.67	1.69	1.59	0.40
thymus, fetal, pool1	10043-101F7	66.29	56.84	5.71	6.03	2.81	1.04	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.61	17.15	2.13	2.66	1.33	0.80	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	15.51	6.57	2.24	0.70	1.26	0.14	0.28
thyroid, adult, pool1	10028-101E1	28.18	15.49	6.35	2.80	0.84	1.77	0.47
thyroid, fetal, donor1	10060-101H6	37.70	23.20	9.76	0.53	2.90	2.11	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	49.27	3.08	12.32	3.08	0.00	0.00
tongue, adult	10203-103F5	20.70	12.33	3.02	1.63	2.09	1.16	0.47
tongue, fetal, donor1	10059-101H5	19.70	12.61	4.73	2.76	1.58	0.39	0.00
tonsil, adult, pool1	10047-101G2	51.79	28.75	2.91	3.31	1.50	0.30	0.00
trachea, adult, pool1	10029-101E2	31.57	15.21	3.11	1.64	1.06	0.90	0.41
trachea, fetal, donor1	10058-101H4	38.85	12.69	2.69	1.92	3.46	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	14.17	11.34	2.48	0.71	2.13	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	31.00	14.59	4.15	2.63	1.52	0.71	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.23	34.47	2.19	2.82	3.13	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	38.05	26.64	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	21.59	16.42	3.81	3.13	0.76	0.59	0.17
umbilical cord, fetal, donor1	10057-101H3	16.69	10.43	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	29.52	29.01	8.87	2.39	1.19	2.56	0.17
uterus, fetal, donor1	10055-101H1	33.28	18.94	8.19	1.02	1.54	0.51	0.00
vagina, adult	10204-103F6	48.46	10.34	2.58	0.00	5.82	2.58	0.00
vein, adult	10191-103E2	38.80	30.69	2.63	2.19	2.19	1.53	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.69	28.57	3.47	6.41	2.67	0.00	0.53